(+91) 8289003597
Nagardeola, Tal Pachora, Maharashtra- 424201 INDIA


Trans-Genica is a preclinical and disease model CRO, committed to building a strong foundation for the future of regulatory and preclinical research in our local community and beyond. At Trans-Genica, we offer research and regulatory services to wide range of industrial sectors such as pharmaceutical, nutraceutical, biotechnology, agrochemical, medical devices companies and academic collaborators. Our scientific work is driven by expertise of highly qualified team of scientists enabling us to provide our industry and academic sponsors with end-to-end solutions for their preclinical testing requirements.

At Trans-Genica, we provide discovery and developmental testing and regulatory safety testing using small laboratory animals (In-vivo studies) as well as well-developed and validated in-vitro tests and models, using bacterial and tissue culture (cell culture). The small laboratory animals we regularly use are laboratory rats, mice, rabbits, and guinea pigs. As per the requirements from time to time, we also work on other species like hamsters and gerbils, etc.Our service portfolio includes acute and short studies, repeat dose studies of varying duration like 28-day and 90-day toxicity studies, genetic toxicology studies, in-vivo disease models, in-vitro toxicity and genotox studies and in-vitro alternatives to animal toxicity studies and in-vitro cell-based screening, efficacy or discovery studies.

We also encourage and participate in different research projects involving the governmental and other non-governmental organizations and research projects of Post Graduate and PhD students.

The routes of administration employed for in-vivo studies are mainly oral, intravenous and dermal routes along with other routes like subcutaneous, intradermal, intraperitoneal, ocular, intraarticular, intrathecal or intracranial administration for which we have expertise and know-how available.

Most of our studies are as per the OECD Guidelines but at the same time we also use other guidelines like ICH, ISO 17025, OPPTS (now OCSPP), CDSCO, CIB&RC, Indian/US/British Pharmacopoeia, etc.

We understand the needs, requirements and expectations of our clients and give our best to provide them the best quality results, within reasonable cost and agreed timelines.

Why Trans-Genica?

Through our dedication to excellence in research, collaboration, and education, we strive to make a significant impact on the global regulatory and pre-clinical landscape. We aim to create a sustainable, world-class ecosystem that attracts the best and brightest minds from local and far off places to our region, empowering them to make a positive difference in the lives of people everywhere.

Expertise and Experience:

We specialize in conducting non-clinical studies to evaluate the safety, efficacy and pharmacokinetics of testing products. We have the expertise and experience to design and conduct studies that meet regulatory requirements and industry best practices. This ensures that studies conducted at our test facility are carried out efficiently and effectively, with highest level of scientific rigor. We believe that by leveraging our expertise, resources, and partnerships, we can create a brighter future for our community and world at large.

Quality and Compliance:

We are committed to maintaining the highest standards of quality and compliance, and becoming the first GLP compliant lab in Maharashtra out of Mumbai-Pune belt, while also following other quality systems like ISO 17025. We are well versed in regulatory compliance and our policies ensure that the studies are conducted in accordance with current guidelines and regulations. This helps our sponsors reduced risk of regulatory issues and delays in approval process.

Animal Welfare and Ethics: We have well developed and well-maintained Animal Facility and in-vitro labs with all the required instrumentation and expertise. The animal facility is well equipped with separate rooms for quarantine, stock and experimental animals. We use laboratory animals with the highest standards of ethical and humane consideration, providing them the best possible husbandry, environmental conditions, handling and care, and reduce their, use, pain and suffering to the least possible.

Reduced Costs: Outsourcing studies to our CRO can help reduce costs associated with staffing, infrastructure, equipment and other resources. By utilizing our services, sponsors can avoid expense of building or maintaining the testing facilities, animal colonies etc.

Accelerated Timelines: We have the capacity to perform studies simultaneously, which can help reduce timelines and accelerate the research and development process. This can be particularly advantages for sponsors working on a tight deadline or facing competitive pressures.

Flexibility: We offer flexible study designs and timelines that can be customized to meet specific needs of our sponsors. This allows our clients to conduct studies that are tailored to their unique requirements.

From our expertise and years of industry experience to flexibility and reduced costs, outsourcing your studies with us can help you save time, money and resources while accelerating the development process.



Reviewing and approving laboratory SOPs. Develop, direct, and implement field investigations. Setting operation budget including capital equipment forecast forward, a new normal that has evolved from generation.

+1 800 700 600

Career in numbers







LAB EDUCATIONAbout Dr. Garrett

Laboratory analysis may be carried out for a number of reasons – usually linked to ensuring a product has been manufactured to meet specifications and regulations and is safe to be released to the market place.

It is imperative then, that the results of the analysis can be trusted, in terms of their accuracy and reproducibility. For a number of reasons – usually linked to ensuring a product has been manufactured to meet specifications.

I greatly appreciate the communication on the process, what we needed to do in terms of providing samples, what to expect from testing.
Dr. Richard Garrett
Head of Laboratory


He has developed essays in the following areas: UPLC-MS/MS, GC-FID, in vivo microdialysis, HPLC-(UV, fluorescence, electrochemical), 2D-gel electrophoresis.

Clinical Areas

Podcasting operational change management inside of workflows to establish a framework. Taking seamless key performance indicators offline.

Research and Publications

Collaboratively administrate empowered markets via plug-and-play networks. Dynamically procrastinate B2C users after installed base benefits.


Taking seamless key performance indicators offline to maximise the long tail. Keeping your eye on the ball while performing a deep dive.


Keeping your eye on the ball while performing a deep dive on the start-up mentality to derive convergence on cross-platform integration.


Dynamically procrastinate B2C users after installed base benefits. Dramatically visualize customer directed convergence without revolutionary ROI.


Nicholas King, PhD


Linda Hoffman, PhD


Melissa Williamson, PhD